Searched for
PLASMODIUM VIVAX
Fever, back pain, and headaches? Don't ignore malaria symptoms, it could be fatalMalaria has been a major cause of concern around the world.
Why Indian startups like Myntra, Jabong are tying up with top-tier universities for research goalsThe inspiration for academic collaborations stems largely from how Silicon Valley has gone about the R&D business.
India among 4 nations that account for 81% deaths from p.vivaxThe report said in 2015, an estimated 212 million cases of malaria occurred worldwide a fall of 22 per cent since 2000 and of 14 per cent s...
New malaria vaccine generates robust immune responseA new malaria vaccine candidate has been found to generate robust immune response while significantly delaying parasitemia in 59 per cent o...
New drug combo therapy may treat malaria in children'Artemisinin-naphthoquine drug-combo should be considered for the treatment of uncomplicated malaria in settings where multiple parasite sp...
Malaria research requires USD 8.3 billion: ReportThe study warns that R&D investments are critical, given the emergence of drug resistance in the malaria parasite and insecticide resistanc...
New drug target to fight malaria identifiedThe disease is caused by Plasmodium parasites, which are transmitted to humans by the infectious bite of an Anopheles mosquito.
Ranbaxy gets CDSCO nod to sell malaria drug 'SynriamTM'"This approval makes SynriamTM one of the few therapies in the world that successfully treats both, Plasmodium vivax and Plasmodium falcipa...
India develops a synthetic anti-malaria drug as an alternative ArtemisininIndia has developed a powerful new malaria drug - an alternative to the global drug of choice Artemisinin - that promises to be a major boo...
- Vaccine makers eye Unicef market for new launches
Indian vaccine makers have begun targeting the Unicef market to launch their novel vaccine molecules.